Skip to main content

Newsweek Names Enovis™ as One of America’s Greatest Workplaces for Diversity 2023

Wilmington, DE, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Today, Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology company, announced that it has been recognized as one of America’s Greatest Workplaces for Diversity by Newsweek. The listing recognizes the best workplaces in the U.S. for their commitment to diversity, equity and inclusion (DEI) in the many categories of diversity.

Newsweek, in cooperation with Plant-A Insights Group, based its scoring on interviews with HR professionals, publicly available data, and an anonymous online survey of U.S. employees, yielding more than 350,000 company reviews to determine the results of the 2023 list.

“Research continually demonstrates that companies with a commitment to a diverse, equitable and inclusive workplace see numerous benefits such as better business performance, increased employee engagement, and an improved ability to attract and retain top talent,” explained Enovis Chief Human Resources Officer Patty Lang. “At Enovis, we value our diverse employee base and encourage our team members to bring individual ideas and perspectives to the table as we know these differences make us stronger. It is an honor to receive this recognition from a well-respected publication like Newsweek.”

To join one of America’s greatest workplaces for diversity, please click here to view current career opportunities at Enovis.

About Enovis
Enovis Corporation (NYSE: ENOV) is an innovation-driven, medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services, and integrated technologies fuels active lifestyles in orthopedics and beyond. For more information about Enovis, please visit

Katie Sweet, Communications 

Primary Logo

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.